Energenesis Biomedical CO.,LTD.

6657

TW0006657000

Biotechnology & Medical Research

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
55.6 ^TWD	+1.09%		+3.73%	-7.95%

Apr. 08	Energenesis Biomedical CO.,LTD. announced a financing transaction	CI
Feb. 29	Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Energenesis Biomedical CO.,LTD.(GTSM:6657) added to S&P Global BMI Index

September 21, 2020 at 12:00 am EDT

Latest news about Energenesis Biomedical CO.,LTD.

Energenesis Biomedical CO.,LTD. announced a financing transaction	Apr. 07	CI
Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10	CI
Energenesis Biomedical CO.,LTD.(TWSE:6657) added to S&P Global BMI Index	23-09-18	CI
Energenesis Biomedical CO.,LTD.(TWSE:6657) added to Taiwan TAIEX Index	23-09-07	CI
Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Energenesis Biomedical CO.,LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-18	CI
Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Energenesis Biomedical CO.,LTD.(TPEX:6657) dropped from S&P Global BMI Index	22-09-19	CI
Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-11	CI
Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-08	CI
Energenesis Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-11	CI
Energenesis Biomedical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-14	CI
Energenesis Biomedical CO.,LTD.(GTSM:6657) added to S&P Global BMI Index	20-09-21	CI
Energenesis Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-12	CI
Energenesis Biomedical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-24	CI
Energenesis Biomedical CO.,LTD. announced that it expects to receive TWD 19.9962 million in funding from SCI Pharmtech, Inc.	19-10-24	CI
Energenesis Biomedical CO.,LTD. announced that it has received TWD 9.9981 million in funding from Poalim Ventures Ltd.	19-10-23	CI
Energenesis Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-12	CI
Energenesis Biomedical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-28	CI

Chart Energenesis Biomedical CO.,LTD.

Duration

Period

More charts

ENERGENESIS BIOMEDICAL CO., LTD. is mainly engaged in the research and development of new drugs. The Company's main product projects include experimental service analysis and reagent sales. The Company's main new drugs include ENERGI-F703, ENERGI-F701, ENERGI-F711, and ENERGI-F706. The ENERGI-F703 indications are diabetic foot ulcers. The ENERGI-F701 indications are abnormal alopecia. The ENERGI-F711 indications are burns. The ENERGI-F706 indications are cachexia.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ENERGENESIS BIOMEDICAL CO.,LTD.	-7.95%	128M
IQVIA HOLDINGS INC.	+0.44%	42.86B
MODERNA, INC.	+12.34%	42.74B
LONZA GROUP AG	+44.30%	41.36B
CELLTRION, INC.	-6.20%	27.68B
ICON PUBLIC LIMITED COMPANY	+5.83%	25.15B
ALNYLAM PHARMACEUTICALS, INC.	-23.42%	18.63B
MEDPACE HOLDINGS, INC.	+28.22%	12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.60%	11.92B
UNITED THERAPEUTICS CORPORATION	+6.64%	11.21B